|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Sales | |||||
| Product | |||||
| Service | |||||
| Total sales | |||||
| Cost of sales: | |||||
| Product | |||||
| Service | |||||
| Total cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expense): | |||||
| Foreign exchange gain (loss) | |||||
| Interest expense | |||||
| Interest income | |||||
| Employee Retention Tax Credit, net of costs to collect | |||||
| Other income, net | |||||
| Total other income, net | |||||
| Loss before income taxes | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Net loss attributable to common shareholders | |||||
| Net loss per common share - basic (in dollars per share) | |||||
| Weighted average common shares outstanding - basic (in shares) | |||||
| Net loss per common share - diluted (in dollars per share) | |||||
| Weighted average common shares outstanding - diluted (in shares) | |||||
Loading...